4:06 PM ET
8-K
Other 8-K Filing
Aptevo Therapeutics Other 8-K Filing
Aptevo Therapeutics entered into Amendment No. 6 to its Rights Agreement, extending the expiration date of its shareholder rights plan (poison pill) to October 23, 2027. The amendment also adjusted the purchase price for the contingent preferred stock rights to $14.56 per one one-thousandth of a share.
- Counterparty
- Broadridge Corporate Issuer Solutions, LLC
- Term
- through Oct 2027